Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 7, 2015; 21(9): 2777-2785
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2777
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2777
Table 7 Adverse events n (%)
| Event | Immunotherapy patients (n = 42)1 | Number of EAAL cellular transfers (n = 242) |
| Fever | 8 (19.05) | 26 (10.74) |
| Chill | 4 (9.52) | 13 (5.37) |
| Headache | 3 (7.14) | 5 (2.07) |
| Nausea | 2 (4.76) | 2 (0.83) |
| Itching | 1 (2.38) | 1 (0.41) |
| Rash | 1 (2.38) | 1 (0.41) |
| Tachycardia | 1 (2.38) | 1 (0.41) |
| Diarrhea | 1 (2.38) | 1 (0.41) |
- Citation: Zhang GQ, Zhao H, Wu JY, Li JY, Yan X, Wang G, Wu LL, Zhang XG, Shao Y, Wang Y, Jiao SC. Prolonged overall survival in gastric cancer patients after adoptive immunotherapy. World J Gastroenterol 2015; 21(9): 2777-2785
- URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2777.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i9.2777